Novavax Inc (NVAX)

EBITDA Growth

-135.62%

Quarterly · Period ending:

NVAX logo

NVAX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-135.62%
NVAX Quarterly EBITDA YoY % (0.00% → -135.62%)
High-resolution chart · PNG

NVAX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
72.567%
-1.1826%
-379.9%
-104.5625%
-240.375%
-69.125%
37.5%
-33.3333%
38.4615%
0%
-60%
-9.0909%
0%
20%
41.1765%
-22.2222%
-8.3333%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.